3 Big Reasons RMD Should Be On Your Watchlist
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide?
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
ResMed Acquires Sleep-Related Wearables Developer Noctrix Health From Angelini Industries For $340M
Resmed completes $340M Noctrix takeover
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
ResMed Inc (NYSE:RMD): A Top Dividend Stock with Strong Profitability and Financial Health
Do Wall Street Analysts Like ResMed Stock?
How Investors Are Reacting To ResMed (RMD) Linking Oura Ring Wearables To Clinical Sleep Care
Is the Options Market Predicting a Spike in ResMed Stock?
ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend
10 Dividend Growth Stocks: May 2025
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down
ResMed Q3 Earnings Call Highlights
RMD Q1 Deep Dive: Mask Portfolio Drives Growth Amid Market Uncertainty and New CFO Appointment
RBC Capital Maintains Outperform on ResMed, Raises Price Target to $321
RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.